EXPOIndustrials · Engineering & ConstructionThe 4 Wall Street analysts covering Exponent, Inc. hold a median 12-month price target of $90 — +25.3% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 86 of 100 as at 15 Oct 2026 — inside the top quartile. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores Exponent, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Volatility (95): The share price has been relatively steady.
Value (54): The shares cost a lot relative to the profits and assets behind them.
Size (28): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on EXPO, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +25.3% from it.
Of the 20 most recent actions, 1 moved their price target up and 2 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 31 July 2026 | JP Morgan | Maintains | Overweight | $80 → $90 |
| 31 July 2026 | UBS | Maintains | Neutral | $75 → $72 |
| 15 May 2026 | JP Morgan | Maintains | Overweight | $95 → $80 |
| 15 May 2026 | JP Morgan | Maintains | Overweight | — |
| 1 May 2026 | UBS | Maintains | Neutral | — |
| 26 Mar 2026 | JP Morgan | Maintains | Overweight | — |
| 26 Jan 2026 | JP Morgan | Initiates | Overweight | — |
| 15 Dec 2025 | UBS | Maintains | Neutral | — |
| 17 Nov 2025 | William Blair | Upgrade | Outperform | — |
| 26 July 2024 | Truist Securities | Reiterates | Buy | — |
| 29 Apr 2024 | Truist Securities | Maintains | Buy | — |
| 2 Feb 2024 | Truist Securities | Maintains | Buy | — |
| 31 July 2023 | Truist Securities | Maintains | Buy | — |
| 1 June 2023 | UBS | Initiates | Neutral | — |
| 5 Apr 2022 | Truist Securities | Maintains | Buy | — |
| 2 Aug 2021 | Truist Securities | Maintains | Buy | — |
| 2 June 2020 | Sidoti & Co. | Maintains | Buy | — |
| 13 May 2020 | Sidoti & Co. | Upgrade | Buy | — |
| 1 May 2020 | Sidoti & Co. | Maintains | Neutral | — |
| 19 Mar 2020 | Sidoti & Co. | Upgrade | Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. EXPO appears on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 16 Oct 2026, Exponent, Inc. returned +7.1% against +16.8% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 24% of US stocks
Cheaper than 20% of US stocks
Cheaper than 8% of US stocks
Cheaper than 11% of US stocks
Higher than 57% of US stocks
Higher than 49% of US stocks
Higher than 77% of US stocks
Higher than 82% of US stocks
Higher than 88% of US stocks
Higher than 94% of US stocks
Higher than 76% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Exponent, Inc. has a market value of $3.4B and an enterprise value of $3.5B.
Revenue in the twelve months to 30 June 2026: $632.5M. The latest quarter grew 12.0% year on year.
Net income over the same four quarters: $111.8M, a 17.7% net margin.
Diluted earnings per share, trailing twelve months: $2.23.
Free cash flow in the twelve months to 30 June 2026: $108.6M, after $9.6M of capital spending.
Exponent, Inc. spent $210.6M on share buybacks and $61.3M on dividends in the twelve months to 30 June 2026.
Trailing P/E: 32.4×; forward P/E: 26.6× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 1.72%, paying out 55% of earnings.
Exponent, Inc. employs 1,012 people — $625K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Exponent, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Exponent hosted an Investor Day event that showcased the multidisciplinary science and engineering capabilities underlying its growth. The event highlighted the breadth of the company's technical expertise.
Why it matters — Investors following EXPO gain insight into the scientific and engineering strengths driving the company's business expansion.
A Zacks Investment Research article examines how Exponent (EXPO) and Gen Digital (GEN) have performed relative to their business-services sector so far this year, comparing the two companies' year-to-date returns against the sector benchmark.
Why it matters — EXPO watchers would care because the piece assesses whether Exponent is keeping pace with or falling behind its sector peers in year-to-date performance.
Zacks Investment Research reported that the average of Wall Street analysts' price targets suggests a potential 25.7% upside for Exponent (EXPO). The article notes the reliability of such metrics is questionable but that positive earnings estimate revisions could support upward movement.
Why it matters — EXPO watchers would care because the article highlights analyst price targets and earnings estimate trends that could signal future stock movement.
Exponent, Inc. held its Q2 2026 earnings call, with the transcript published on Seeking Alpha covering management's discussion of the company's quarterly financial results.
Why it matters — The earnings call transcript provides EXPO investors with direct insight into management's commentary on the company's second-quarter performance and outlook.
Exponent reported double-digit revenue and earnings growth for Q2 2026, driven by demand for AI-related user research, utility risk management, and dispute consulting in consumer products, chemicals, and transportation.
Why it matters — The strong quarterly results highlight several growth drivers for Exponent, including AI-related consulting, utility-sector work, and litigation support across multiple industries.
The 4 Wall Street analysts covering Exponent, Inc. have a median 12-month price target of $90, with estimates ranging from $72 to $90. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 4 analysts covering Exponent, Inc., 3 rate it a Buy, 1 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Exponent, Inc. 86 out of 100 across roughly 4,600 US stocks as at 15 Oct 2026. None of this is personal advice — it does not consider your circumstances.
As at 15 Oct 2026, Exponent, Inc. ranks 86 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (95 of 100).
No one can know that. What the data says: the median 12-month target from 4 analysts implies +25.3% from the last close, and Ticker Nerd's factor model ranks Exponent, Inc. 86 out of 100 as at 15 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Exponent, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for EXPO are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $72 to $90 over the next 12 months.
Exponent, Inc. returned +7.1% over the 12 months to 16 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.
Exponent Inc. is a science and engineering consulting company headquartered in Menlo Park, California.
The most recent item we track (GlobeNewsWire, 30 Sept 2026): "Exponent Hosts Investor Day". Exponent hosted an Investor Day event that showcased the multidisciplinary science and engineering capabilities underlying its growth. The event highlighted the breadth of the company's technical expertise.
Exponent Inc. is a science and engineering consulting company headquartered in Menlo Park, California. Exponent Inc. provides technical advisory services to businesses, law firms, insurers, and government clients across a wide range of industries, helping address complex questions involving product safety, reliability, regulatory compliance, accident investigation, and litigation support. Its work spans engineering, environmental, and health-related issues, drawing on multidisciplinary expertise in areas such as materials, biomechanics, data sciences, human factors, and chemical regulation. The company serves clients involved in product development, industrial operations, and scientific risk assessment, with services designed to analyze failures, improve designs, and support decision-making in technically demanding situations. Exponent Inc. plays a specialized role in the financial market as a professional services provider focused on high-value consulting work in science, engineering, and health sciences.
CEO Dr. Catherine Ford Corrigan P.E., Ph.D. · 1,012 employees · United States · https://www.exponent.com
